Breaking Finance News

Zacks Investment Research announced Arotech Corporation (NASDAQ:ARTX), bumping up its stock price target to $3.75 today

Yesterday Arotech Corporation (NASDAQ:ARTX) traded 0.00% even at $3.45. The company’s 50-day moving average is $3.43 and its 200-day moving average is $3.41. The last closing price is up 2.56% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time period. 321,357 shares of the stock traded hands, up from an average trading volume of 201,778

In a report released on 06/20/2017 Zacks Investment Research increased the stock price target of Arotech Corporation (NASDAQ:ARTX) to $3.75 indicating a possible upside of 0.09%.

See Chart Below

Arotech Corporation (NASDAQ:ARTX)

Arotech Corporation has a 52 week low of $2.25 and a 52 week high of $5.00 The company’s market cap is currently $0.

General Information About Arotech Corporation (NASDAQ:ARTX)

Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division. The Company's Training and Simulation Division develops, manufactures and markets multimedia and interactive digital solutions for engineering, use-of-force training and operator training of military, law enforcement, security, emergency services and other personnel. The Company's Power Systems Division provides battery solutions, energy management and power distribution technologies and product design and manufacturing services for the aerospace, defense, law enforcement, homeland security markets, and it manufactures and sells rechargeable batteries for defense and security products and medical and industrial applications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.